oxiconazole has been researched along with amphotericin b in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Mani Chandrika, KVS; Sharma, S | 1 |
| Chatterjee, PK; Sharma, S; Singh, SM | 1 |
1 review(s) available for oxiconazole and amphotericin b
| Article | Year |
|---|---|
Promising antifungal agents: A minireview.
Topics: Antifungal Agents; Drug Design; Fungi; Humans; Molecular Structure; Mycoses; Structure-Activity Relationship | 2020 |
2 other study(ies) available for oxiconazole and amphotericin b
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Clinical and experimental mycotic keratitis caused by Aspergillus terreus and the effect of subconjunctival oxiconazole treatment in the animal model.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Corneal Ulcer; Disease Models, Animal; Female; Flucytosine; Humans; Imidazoles; Ketoconazole; Male; Middle Aged; Morpholines; Rabbits | 1990 |